专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

11. 发明申请

US20160280995A1 LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE 有权
标题翻译：液晶组合物和液晶显示装置
公开(公告)号：US20160280995A1
公开(公告)日：2016-09-29
申请号：US15035486
申请日：2014-10-03
申请人： JNC CORPORATION , JNC PETROCHEMICAL CORPORATION
发明人： YOSHIMASA FURUSATO , MASAYUKI SAITO
IPC分类号： C09K19/34 , C09K19/54 , G02F1/1362 , C07C43/215 , C07C25/18 , C07D309/06 , C09K19/30 , C07C43/205
CPC分类号： C09K19/3402 , C07C25/18 , C07C43/205 , C07C43/215 , C07C2601/14 , C07D309/06 , C09K19/3001 , C09K19/3003 , C09K19/3066 , C09K19/3068 , C09K19/542 , C09K2019/0444 , C09K2019/0448 , C09K2019/122 , C09K2019/123 , C09K2019/3004 , C09K2019/3009 , C09K2019/301 , C09K2019/3016 , C09K2019/3422 , C09K2019/3425 , C09K2019/548 , G02F1/1362
摘要： The composition contains a specific compound having a high maximum temperature and a low minimum temperature as a first component and has negative dielectric anisotropy, and may further contain a specific compound having large negative dielectric anisotropy as a second component, a specific compound having a high maximum temperature or small viscosity as a third component, a specific compound having large negative dielectric anisotropy as a fourth component and a specific compound having a polymerizable group as an additive component.
摘要翻译：组合物含有作为第一成分的具有高最高温度和低最低温度的特定化合物，并且具有负介电各向异性，并且还可以含有具有大的负介电各向异性作为第二组分的特定化合物，具有高最大值的特定化合物作为第三成分的温度或小粘度，具有大的负介电各向异性作为第四组分的具体化合物和具有可聚合基团的具体化合物作为添加剂组分。

12. 发明授权

US09454076B2 Molecular glass photoresists containing bisphenol a framework and method for preparing the same and use thereof 有权
标题翻译：含有双酚a骨架的分子玻璃光致抗蚀剂及其制备方法及其应用
公开(公告)号：US09454076B2
公开(公告)日：2016-09-27
申请号：US14385238
申请日：2012-05-18
申请人： Guoqiang Yang , Jian Xu , Li Chen , Shuangqing Wang , Shayu Li
发明人： Guoqiang Yang , Jian Xu , Li Chen , Shuangqing Wang , Shayu Li
IPC分类号： C07C43/205 , G03F7/004 , C07C69/96 , C07C39/16 , C07C39/17 , C07C43/21 , G03F7/00 , G03F7/038 , G03F7/039 , C07C37/16 , C07C39/15 , C07C41/01 , C07C68/06
CPC分类号： G03F7/0045 , C07C37/16 , C07C39/15 , C07C39/16 , C07C39/17 , C07C41/01 , C07C43/205 , C07C43/2055 , C07C43/21 , C07C68/06 , C07C69/96 , C07C2603/92 , G03F7/0002 , G03F7/0382 , G03F7/0392
摘要： The present invention provides a class of molecular glass photoresist (I and II) comprising bisphenol A as a main structure and their preparation. The molecular glass photoresist is formulated with a photoacid generator, a cross-linking agent, a photoresist solvent, and other additives into a positive or negative photoresist. A photoresist with a uniform thickness is formed on a silicon wafer by spin-coating. The photoresist formulation can be used in modern lithography, such as 248 nm photolithography, 193 nm photolithography, extreme-ultraviolet (EUV) lithography, nanoimprint lithography, electron beam lithography, and particularly in the EUV-lithography technique.

13. 发明申请

US20160152538A1 REPELLENT EFFECTIVE AGAINST ANOPHELES GAMBIAE 审中-公开
标题翻译：有效的对抗敌人
公开(公告)号：US20160152538A1
公开(公告)日：2016-06-02
申请号：US14956041
申请日：2015-12-01
申请人： Simon Fraser University
发明人： Erika Plettner , Bernard Roitberg
IPC分类号： C07C43/215 , A01N31/16 , C07C43/205
CPC分类号： A01N31/16
摘要： The present disclosure describes methods for repelling an Anopheles gambiae including applying to a site of interest an effective amount of a compound of Formula I: wherein: R1 is methyl, ethyl, propyl, n-butyl, or allyl; R2 is at positions 2, 3 or 4 and is H, methyl, ethyl, propyl, n-butyl, or allyl; and R3 is optionally present at positions 2, 3 and 4, and is allyl; with the provisos that when R2 is at position 2, R3 if present is at position 3, or when R2 is at position 3, R3 if present is at positions 2 or 4, or when R2 is at position 4, R3 if present is at position 2; and with the proviso that the compound of Formula I does not include a compound according to Formula II: wherein R1′ is methyl, ethyl, propyl, n-butyl, or allyl; or mixture thereof to a site of interest.
摘要翻译：本公开描述了用于排斥冈比亚按摩症的方法，包括施用有效量的式I化合物：其中：R1是甲基，乙基，丙基，正丁基或烯丙基; R2位于2,3或4位，为H，甲基，乙基，丙基，正丁基或烯丙基; R3任选存在于2,3和4位，并且是烯丙基; 条件是当R2在位置2时，R3如果存在的是位置3，或者当R2在3位时，R3如果存在的是位置2或4，或当R2在第4位时，如果存在的话是R3 位置2; 并且条件是式I化合物不包括根据式II的化合物：其中R 1'是甲基，乙基，丙基，正丁基或烯丙基; 或其混合物到感兴趣的部位。

14. 发明授权

US09335316B2 Bisphenol A compounds useful as markers for liquid hydrocarbons and other fuels and oils 有权
标题翻译：双酚A化合物可用作液体烃和其他燃料和油的标记物
公开(公告)号：US09335316B2
公开(公告)日：2016-05-10
申请号：US14124780
申请日：2012-06-19
申请人： George D. Green , Raymond J. Swedo , Robert Butterick, III
发明人： George D. Green , Raymond J. Swedo , Robert Butterick, III
IPC分类号： C07C43/205 , G01N33/28 , G01N33/22 , C10L1/00 , C10L1/185 , C10M129/16
CPC分类号： G01N33/2882 , C07C43/2055 , C10L1/003 , C10L1/1852 , C10M129/16 , C10M2207/04 , C10N2240/56 , G01N33/22
摘要： A compound having formula (I), wherein R1 and R2 independently represent hydrogen or C1-C4 alkyl groups, and G represents hydrogen or at least one substituent selected from the group consisting of C1-C18 alkyl and C1-C18 alkoxy; provided that when R1 and R2 represent hydrogen, G does not represent hydrogen, 4-methyl, 4-methoxy, 3-methoxy, 2,6-dipropargyl, 4-vinyl, 4-ethynyl or 3-ethynyl.
摘要翻译：具有式（I）的化合物，其中R1和R2独立地表示氢或C1-C4烷基，G表示氢或至少一个选自C1-C18烷基和C1-C18烷氧基的取代基; 条件是当R 1和R 2表示氢时，G不表示氢，4-甲基，4-甲氧基，3-甲氧基，2,6-二丙炔基，4-乙烯基，4-乙炔基或3-乙炔基。

15. 发明授权

US09187409B2 Synthesis of Aliskiren 有权
标题翻译：阿利吉仑的合成
公开(公告)号：US09187409B2
公开(公告)日：2015-11-17
申请号：US13879849
申请日：2011-10-19
申请人： Rama Shankar , Vadali Lakshmana Rao , Palla Vijay Kumar , Saidugari Swamy , Dasari Srinivasa Rao , Srinivasa Rao Potla , Mittapelly Nagaraju , Jaldu Ravikanth , Vijaya Krishna Ravi , Seshadri Rao Manukonda , Dandala Ramesh
发明人： Rama Shankar , Vadali Lakshmana Rao , Palla Vijay Kumar , Saidugari Swamy , Dasari Srinivasa Rao , Srinivasa Rao Potla , Mittapelly Nagaraju , Jaldu Ravikanth , Vijaya Krishna Ravi , Seshadri Rao Manukonda , Dandala Ramesh
IPC分类号： C07C231/12 , C07C237/22 , C07C233/00 , C07C43/205 , C07C231/14 , C07C43/215 , C07C241/00 , C07C255/29 , C07C247/10 , C07D307/33
CPC分类号： C07C231/14 , C07C43/215 , C07C231/12 , C07C241/00 , C07C247/10 , C07C255/29 , C07D307/33 , C07C237/22
摘要： The present invention provides novel process for the preparation of renin inhibitor Aliskiren or its derivatives, and its pharmaceutically acceptable salts. The present invention also provides novel intermediates used in the preparation of Aliskiren.
摘要翻译：本发明提供了制备肾素抑制剂阿利吉仑或其衍生物及其药学上可接受的盐的新方法。本发明还提供了用于制备阿利吉仑的新型中间体。

16. 发明申请

US20150267035A1 TRI-SUBSTITUTED AROMATIC-CONTAINING ADDITIVES AND SURFACTANTS AND METHODS FOR USE 有权
标题翻译：三取代含芳香的添加剂和表面活性剂及其使用方法
公开(公告)号：US20150267035A1
公开(公告)日：2015-09-24
申请号：US14661814
申请日：2015-03-18
申请人： RHODIA OPERATIONS
发明人： Eugene J. Anderson, JR. , Derek Pakenham , Nemesio Martinez-Castro , Jose P. Ruiz , Michael Rhodes , Lichang Zhou
IPC分类号： C08K5/13 , C07C43/205
CPC分类号： C07C43/2055 , C07C37/14 , C07C41/03 , C07C69/54 , C08F20/30 , C08F22/12 , C08F2220/306 , C08K3/04 , C08K5/13 , C07C39/15
摘要： Disclosed are novel tri-substituted aromatic-alkoxylated surface active compounds. Also provided is a method of preparing an aqueous coating composition such as a latex paint including the above components.
摘要翻译：公开了新的三取代芳族 - 烷氧基化表面活性化合物。还提供了制备水性涂料组合物如包括上述组分的乳胶漆的方法。

17. 发明授权

US09079836B2 Compound having 2-fluorophenyloxymethane structure, a method for preparing the same, a liquid crystal composition and a liquid crystal device 有权
标题翻译：具有2-氟苯氧基甲烷结构的化合物，其制备方法，液晶组合物和液晶装置
公开(公告)号：US09079836B2
公开(公告)日：2015-07-14
申请号：US14346498
申请日：2012-12-20
申请人： DIC Corporation
发明人： Kenta Tojo , Tetsuo Kusumoto
IPC分类号： C07C43/205 , C07C41/01 , C07F5/02 , G02F1/13 , C09K19/06 , C09K19/32 , C07C43/225 , C09K19/40 , C07C41/30
CPC分类号： C07C41/01 , C07C41/30 , C07C43/225 , C07F5/02 , C09K19/062 , C09K19/322 , C09K19/404 , G02F1/13
摘要： It is an object of the present invention to provide a compound having both a low viscosity (η) and good miscibility with another liquid crystal compound; it is another object of the present invention to provide a method for producing the same. It is another object of the present invention to provide a liquid crystal composition containing such a compound; it is another object of the present invention to provide a liquid crystal display device in which the compound is used.There are provided a compound represented by Formula (1), a liquid crystal composition containing such a compound, a liquid crystal device in which this liquid crystal composition is used, a method for producing the compound represented by Formula (1), and compounds represented by Formulae (4) and (5) that are materials used in such a method.
摘要翻译：本发明的目的是提供一种具有低粘度（＆eegr）和与另一种液晶化合物的良好混溶性的化合物; 本发明的另一个目的是提供一种制造该方法的方法。本发明的另一个目的是提供一种含有这种化合物的液晶组合物; 本发明的另一个目的是提供一种使用该化合物的液晶显示装置。提供由式（1）表示的化合物，含有这种化合物的液晶组合物，使用该液晶组合物的液晶装置，由式（1）表示的化合物的制备方法，通过式（4）和（5），这些方法中使用的材料。

18. 发明授权

US09029568B2 Branched hetero polyfunctional polyoxyalkylene compound and intermediate thereof 有权
标题翻译：支链杂多官能聚氧化烯化合物及其中间体
公开(公告)号：US09029568B2
公开(公告)日：2015-05-12
申请号：US13632353
申请日：2012-10-01
申请人： NOF Corporation
发明人： Masaki Kamiya , Ken-ichiro Nakamoto
IPC分类号： C07D403/14 , C07C211/10 , C07C217/08 , C07C43/205 , C07D207/36 , C07D207/46 , C08G65/08
CPC分类号： C07C217/08 , C07C43/205 , C07D207/36 , C07D207/46 , C08G65/08 , C08G65/33313 , C08G65/33317 , C08L2203/02
摘要： A branched hetero polyfunctional polyoxyalkylene compound represented by the following formula (1): wherein Z represents a hydroxyl group-removed residue of pentaerythritol or dipentaerythritol, OA1 and OA2 represent an oxyalkylene group having 2 to 4 carbon atoms, L1, L2 and L3 represent an alkylene group or an alkylene group that contains an ester bond, a urethane bond, an amide bond, an ether bond, a carbonate bond, a secondary amino group or a urea bond, X and Y are different from each other and represent a functional group capable of a chemical reaction; m and n are an average number of moles of the oxyalkylene group added, m represents 5 to 1,000, n represents 0 to 1,000, and p, q and r represent 0 or 1; and s1 is an integer of 2 or more and s1+s2=4 or 6.
摘要翻译：由下式（1）表示的支链异多官能聚氧化烯化合物：其中Z表示季戊四醇或二季戊四醇的羟基去除残基，OA1和OA2表示碳原子数2〜4的氧化烯基，L1，L2和L3表示亚烷基或含有酯键，氨基甲酸酯键，酰胺键，醚键，碳酸键，仲氨基或脲键的亚烷基，X和Y彼此不同，表示官能团能够发生化学反应; m和n是加入的氧化烯基的平均摩尔数，m表示5至1,000，n表示0至1,000，p，q和r表示0或1; s1为2以上的整数，s1 + s2 = 4或6。

19. 发明申请

US20150037735A1 MOLECULAR GLASS PHOTORESISTS CONTAINING BISPHENOL A FRAMEWORK AND METHOD FOR PREPARING THE SAME AND USE THEREOF 有权
标题翻译：包含双酚A框架的分子玻璃光电子及其制备方法及其用途
公开(公告)号：US20150037735A1
公开(公告)日：2015-02-05
申请号：US14385238
申请日：2012-05-18
申请人： Guoqiang Yang , Jian Xu , Li Chen , Shuangqing Wang , Shayu Li
发明人： Guoqiang Yang , Jian Xu , Li Chen , Shuangqing Wang , Shayu Li
IPC分类号： G03F7/004 , C07C39/15 , C07C37/16 , C07C68/06 , C07C41/01 , C07C43/205 , C07C69/96
CPC分类号： G03F7/0045 , C07C37/16 , C07C39/15 , C07C39/16 , C07C39/17 , C07C41/01 , C07C43/205 , C07C43/2055 , C07C43/21 , C07C68/06 , C07C69/96 , C07C2603/92 , G03F7/0002 , G03F7/0382 , G03F7/0392
摘要： The present invention provides a class of molecular glass photoresist (I and II) comprising bisphenol A as a main structure and their preparation. The molecular glass photoresist is formulated with a photoacid generator, a cross-linking agent, a photoresist solvent, and other additives into a positive or negative photoresist. A photoresist with a uniform thickness is formed on a silicon wafer by spin-coating. The photoresist formulation can be used in modern lithography, such as 248 nm photolithography, 193 nm photolithography, extreme-ultraviolet (EUV) lithography, nanoimprint lithography, electron beam lithography, and particularly in the EUV-lithography technique.
摘要翻译：本发明提供一种以双酚A为主要结构的分子玻璃光致抗蚀剂（I和II）及其制备方法。将分子玻璃光致抗蚀剂与光致酸发生剂，交联剂，光致抗蚀剂溶剂和其它添加剂一起配制成正性或负性光致抗蚀剂。通过旋涂在硅晶片上形成具有均匀厚度的光致抗蚀剂。光致抗蚀剂制剂可用于现代光刻，例如248nm光刻，193nm光刻，极紫外（EUV）光刻，纳米压印光刻，电子束光刻，尤其是在EUV光刻技术中。

20. 发明授权

US08946224B2 Substituted [1,2,4]triazolo[4,3-A]pyrazines for medicaments and pharmaceutical compositions 有权
标题翻译：用于药物和药物组合物的取代的[1,2,4]三唑并[4,3-A]吡嗪
公开(公告)号：US08946224B2
公开(公告)日：2015-02-03
申请号：US13883713
申请日：2011-11-11
申请人： Mark Craighead , Ronald Palin , Neil Murray , Derek Lindsay
发明人： Mark Craighead , Ronald Palin , Neil Murray , Derek Lindsay
IPC分类号： A61K31/4985 , C07D487/04 , C07D498/06 , C07D413/12 , C07C63/64 , C07D213/60 , C07C217/58 , C07D403/06 , C07C69/12 , C07C235/16 , C07D257/04 , C07D313/04 , C07D407/06 , C07C43/205 , C07C215/46 , C07C255/25 , C07D205/08 , C07D281/06 , C07D417/06 , C07D413/04 , C07D401/04 , C07C63/66 , C07D499/88 , C07D401/12 , C07D519/00 , C07D209/18 , C07D307/00 , C07D501/00 , C07C233/22 , C07D473/00 , C07H19/052 , C07C251/40 , C07D403/12 , C07D513/06 , C07C251/54 , C07C257/14 , C07C251/48 , C07C57/00 , C07C233/36 , C07H19/173 , C07D411/10 , C07C229/18 , C07D295/02 , C07H19/06 , C07C235/28 , C07D233/54 , C07J5/00 , C07D471/04 , C07D241/04 , C07D235/16 , C07D277/40 , C07D417/12 , C07D309/32 , C07C237/20 , C07C251/58 , C07D401/14 , C07D491/04
CPC分类号： C07D487/04 , C07C43/205 , C07C57/00 , C07C63/64 , C07C63/66 , C07C69/12 , C07C215/46 , C07C217/58 , C07C229/18 , C07C233/22 , C07C233/36 , C07C235/16 , C07C235/28 , C07C237/20 , C07C251/40 , C07C251/48 , C07C251/54 , C07C251/58 , C07C255/25 , C07C257/14 , C07C2601/16 , C07C2602/10 , C07C2603/74 , C07D205/08 , C07D209/18 , C07D213/60 , C07D233/54 , C07D235/16 , C07D241/04 , C07D257/04 , C07D277/40 , C07D281/06 , C07D295/02 , C07D307/00 , C07D309/32 , C07D313/04 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/06 , C07D403/12 , C07D407/06 , C07D411/10 , C07D413/04 , C07D413/12 , C07D417/06 , C07D417/12 , C07D471/04 , C07D473/00 , C07D491/04 , C07D498/06 , C07D499/88 , C07D501/00 , C07D513/06 , C07D519/00 , C07H19/052 , C07H19/06 , C07H19/173 , C07J5/00 , C07J71/0031
摘要： The present invention relates to derivatives of known active pharmaceutical compounds. These derivatives are differentiated from the parent active compound by virtue of being redox derivatives of the active compound. This means that one or more of the functional groups in the active compound has been converted to another group in one or more reactions which may be considered to represent a change of oxidation state. We refer to these compounds generally as redox derivatives. The derivatives of the invention may be related to the original parent active pharmaceutical compound by only a single step transformation, or may be related via several synthetic steps including one or more changes of oxidation state. Exemplary derivatives have the formula
摘要翻译：本发明涉及已知的活性药物化合物的衍生物。由于活性化合物的氧化还原衍生物，这些衍生物与母体活性化合物不同。这意味着活性化合物中的一个或多个官能团已经在一个或多个反应中被转化为另一个基团，这可被认为代表氧化态的变化。我们通常将这些化合物称为氧化还原衍生物。本发明的衍生物可以仅通过单步转化与原始的母体活性药物化合物相关，或者可以通过包括氧化态的一个或多个变化的几个合成步骤相关。示例性衍生物具有式

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式